Level Chart

Basic Info

Becton Dickinson and Co (BDX) - Life Sciences Revenue is at a current level of 1.26B, down from 1.304B last quarter and up from 1.226B one year ago. This is a change of -3.37% from last quarter and 2.77% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 1.26B
Latest Period Jun 2024
Last Updated Aug 1 2024, 09:22 EDT
Next Release Jan 31 2025, 08:30 EST (E)
Average Growth Rate 7.39%
Value from Last Quarter 1.304B
Change from Last Quarter -3.37%
Value from 1 Year Ago 1.226B
Change from 1 Year Ago 2.77%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
June 30, 2024 1.26B
March 31, 2024 1.304B
December 31, 2023 1.288B
September 30, 2023 1.33B
June 30, 2023 1.226B
March 31, 2023 1.275B
December 31, 2022 1.302B
September 30, 2022 1.287B
June 30, 2022 1.309B
March 31, 2022 1.485B
Date Value
December 31, 2021 1.483B
September 30, 2021 1.532B
June 30, 2021 1.433B
March 31, 2021 1.586B
December 31, 2020 1.979B
September 30, 2020 1.488B
June 30, 2020 951.00M
March 31, 2020 1.113B
December 31, 2019 1.123B

Basic Info

Becton Dickinson and Co (BDX) - Life Sciences Revenue is at a current level of 1.26B, down from 1.304B last quarter and up from 1.226B one year ago. This is a change of -3.37% from last quarter and 2.77% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 1.26B
Latest Period Jun 2024
Last Updated Aug 1 2024, 09:22 EDT
Next Release Jan 31 2025, 08:30 EST (E)
Average Growth Rate 7.39%
Value from Last Quarter 1.304B
Change from Last Quarter -3.37%
Value from 1 Year Ago 1.226B
Change from 1 Year Ago 2.77%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
BDX Becton Dickinson & Co -0.89%